The Electrospinning Company was established in 2010 as a spin-out by the UK Science and Technology Research Council (STFC) and is based on the growing Harwell Science and Innovation Campus, near Oxford.
They have developed the expert know-how to design, develop and manufacture materials for use in regenerative medicine which seeks to replace or repair damaged or diseased cells or tissues or to simulate the body’s own repair mechanisms.
Electrospun scaffolds are being used to help regenerate bone tissue, human cornea, tendon surgery and wound care. They then degrade or are reabsorb naturally once the patient has healed.
The company is already manufacturing and supplying materials for use in an FDA approved medical device. This round of funding, which is coupled with an Innovate UK loan, will provide the company with the platform to on board a number of further tier 1 manufacturing clients.